Intec Parent Inc

Indaptus Therapeutics Inc is a clinical-stage biotechnology company. It focuses on developing a novel, systemically administered anti-cancer immunotherapy for cancer patients. The company’s primary aim is to treat various solid tumours by activating the body's innate immune system. Operating within the biotechnology and healthcare sector, Indaptus Therapeutics Inc focuses on its proprietary platform that exploits bacteria’s natural ability to activate immune pathways. Its approach seeks to stimulate the body's immune response to directly target and eliminate cancer cells, potentially offering new therapeutic options for patients. Monitor the INDP share price by adding it to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.